Aktiesnakken — Maj 2011
-
Hvis man vil overvægte store defensive selskaber med globalt salg, et stort frit cashflow og lav gæld, hvem skal man så vælge i c20?
-
OK, så alle danske?
-
ok tak, det er danske som anbefaler det de næste 6 måneder, er der ikke andre?
-
coloplast
-
novozymes
-
william demant
-
Kontant ;0)
-
hvorfor skal det være c20?
-
tag GSK
-
de køber 500K aktier tilbage dagligt
-
jeg er 38% kontant pt. jeg vil se lidt på gsk, tak for svar.
-
cliffy
-
men de har købt en masse pleje. Stiefl blandt andet
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind